TrialAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology.

Stephen P Schauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.